Quick Answer
Cardio Diagnostics Holdings, Inc. reported Common Stock Shares Outstanding of 1.83 million shares for the year ending 2025.
- Cardio Diagnostics Holdings, Inc. showed a decrease of -96.5% in Common Stock Shares Outstanding from 2025 to 2025.
- This data is from Cardio Diagnostics Holdings, Inc.'s annual report (Form 10-K), filed with the SEC on March 13, 2026.
- XBRL data for this metric is available from 2021 to 2025 (6 years of filings). Earlier data may not exist in machine-readable XBRL format as companies adopted electronic filing at different times.
- Quarterly values from 10-Q filings: Q1 2022: 1.63 million shares | Q2 2022: 1.63 million shares | Q3 2022: 1.63 million shares | Q1 2023: 9.62 million shares | Q2 2023: 11.18 million shares | Q3 2023: 13.12 million shares | Q2 2024: 23.31 million shares | Q3 2024: 30.34 million shares | Q1 2025: 1.74 million shares | Q2 2025: 1.74 million shares | Q3 2025: 1.77 million shares.
- Over the full 6 years of available data (2021 to 2025), Cardio Diagnostics Holdings, Inc.'s Common Stock Shares Outstanding has grown by 48.2%.
- Historical annual values: Fiscal year 2025: 1.83 million shares | Fiscal year 2025: 52.16 million shares | Fiscal year 2024: 1.53 million shares | Fiscal year 2023: 20.54 million shares | Fiscal year 2022: 9.51 million shares | Fiscal year 2021: 1.23 million shares.
- Data sourced from SEC EDGAR public filings as of August 10, 2026.
Last verified: